This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of July 2024. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.
Item | Value |
---|---|
Country | United States |
Wikipedia page | https://en.wikipedia.org/wiki/Bill_%26_Melinda_Gates_Foundation |
Best overview URL | https://en.wikipedia.org/wiki/Bill_%26_Melinda_Gates_Foundation |
Facebook username | gatesfoundation |
LinkedIn username | bill-&-melinda-gates-foundation |
Website | https://www.gatesfoundation.org/ |
Donations URL | https://www.gatesfoundation.org/How-We-Work/Quick-Links/Grants-Database |
Twitter username | gatesfoundation |
Page on philosophy informing donations | https://www.gatesfoundation.org/What-We-Do |
Grant application process page | https://www.gatesfoundation.org/How-We-Work/General-Information/Grantseeker-FAQ |
Regularity with which donor updates donations data | continuous updates |
Regularity with which Donations List Website updates donations data (after donor update) | irregular |
Lag with which donor updates donations data | months |
Lag with which Donations List Website updates donations data (after donor update) | years |
Data entry method on Donations List Website | SQL insertion commands generated by script https://github.com/riceissa/gates-foundation-iati-processing |
Brief history: The Gates Foundation launched in 2000, with precursors starting in the 1990s, financed by the personal wealth of co-founder Bill Gates from Microsoft. Starting 2005, it scaled up its giving significantly after a large funding commitment from Warren Buffett
Brief notes on broad donor philosophy and major focus areas: See https://www.gatesfoundation.org/Who-We-Are/General-Information/Foundation-Factsheet for the grantmaking areas. The four grantmaking areas are the Global Development Program, Global Health Program, Global Policy and Advocacy, and United States Program. Within the United States Program the focus is on K-12 education, the Internet, and emergency relief
Notes on grant publication logistics: Although the Gates Foundation has a grants database on its website, as well as individual grant pages for every grant, we use the IATI data instead, because it can be processed programmatically (the data on the site does not allow for full data download or easy programmatic processing). This leads to a few problems: first, IATI data does not include grants made in the United States, since it focuses on development assistance (DA) spending. Second, IATI data is updated more infrequently. Third, it may sometimes omit some information that is present in the grants database
Full donor page for donor Bill and Melinda Gates Foundation
Item | Value |
---|---|
Country | |
Facebook page | coloradostateuniversity |
Website | http://www.colostate.edu/ |
Twitter username | coloradostateu |
Wikipedia page | https://en.wikipedia.org/wiki/Colorado_State_University |
Instagram username | coloradostateuniversity |
Full donee page for donee Colorado State University
Item | Value |
---|
Cause area | Count | Median | Mean | Minimum | 10th percentile | 20th percentile | 30th percentile | 40th percentile | 50th percentile | 60th percentile | 70th percentile | 80th percentile | 90th percentile | Maximum |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Overall | 45 | 121,021 | 428,952 | -2,800 | 0 | 0 | 21,120 | 100,000 | 121,021 | 206,422 | 593,628 | 679,634 | 1,173,007 | 2,599,996 |
Global health | 44 | 121,021 | 436,428 | -2,800 | 0 | 0 | 21,120 | 100,000 | 121,021 | 208,591 | 593,628 | 862,470 | 1,173,007 | 2,599,996 |
Nutrition | 1 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 |
If you hover over a cell for a given cause area and year, you will get a tooltip with the number of donees and the number of donations.
Note: Cause area classification used here may not match that used by donor for all cases.
Cause area | Number of donations | Total | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Global health (filter this donor) | 44 | 19,202,819.21 | 1,930,487.00 | 120,640.38 | -526.31 | 2,810,641.74 | 2,155,224.00 | 1,456,098.00 | 1,200,758.59 | 3,478,903.81 | 100,000.00 | 900,451.00 | 1,348,384.00 | 3,701,757.00 |
Nutrition (filter this donor) | 1 | 100,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 100,000.00 | 0.00 | 0.00 | 0.00 |
Total | 45 | 19,302,819.21 | 1,930,487.00 | 120,640.38 | -526.31 | 2,810,641.74 | 2,155,224.00 | 1,456,098.00 | 1,200,758.59 | 3,478,903.81 | 200,000.00 | 900,451.00 | 1,348,384.00 | 3,701,757.00 |
Graph of spending by cause area and year (incremental, not cumulative)
Graph of spending by cause area and year (cumulative)
There are no documents associated with this combination of donor and donee.
Graph of all donations (with known year of donation), showing the timeframe of donations
Amount (current USD) | Amount rank (out of 45) | Donation date | Cause area | URL | Influencer | Notes |
---|---|---|---|---|---|---|
1,768,326.00 | 3 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to enable the discovery and development of more effective drug regimens for drug sensitive and drug resistant tuberculosis (TB) disease; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
162,161.00 | 21 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to promote the development of new antibiotics for the treatment of tuberculosis and other mycobacterial diseases; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
121,021.00 | 23 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to promote the development of new antibiotics for the treatment of tuberculosis and other mycobacterial diseases; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
-85.58 | 36 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to block residual malaria transmission by vaccinating cattle with selected, essential antigens from the mosquito Anopheles so that they produce antibodies that are lethal to the mosquitoes that feed on them.; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
-91.38 | 37 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to validate a new mouse model resembling human pathology for TB drug development. Evaluation of a new murine model for testing tuberculosis chemotherapy. Investment start date: 10/24/2011 to end date: 10/31/2016. Grantee name: Colorado State University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
-27.56 | 34 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to develop a robust, inexpensive, facile point-of-care test for accurate diagnosis of tuberculosis for use in high burden, low-income countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
-176.10 | 41 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to validate a novel approach and series of biomarkers for the diagnosis of tuberculosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
-157.01 | 39 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to reduce the incidence of malaria, lymphatic filariasis and soil transmitted helminth infections in Burkina Faso by administering the anti-parasitic drug ivermectin and insecticide treated nets during the dry-to-rainy seasonal transition; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
-157.01 | 39 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to reduce the incidence of malaria, lymphatic filariasis and soil transmitted helminth infections in Burkina Faso by administering the anti-parasitic drug ivermectin and insecticide treated nets during the dry-to-rainy seasonal transition; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
-152.08 | 38 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to evaluate the metabolic status of host granulomatous tissue and TB during drug treatment and disease relapse in the mouse model of TB and during disease progression in the mouse and non-human primate models of TB; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
-60.21 | 35 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to develop methods to detect specific volatile organic compound (VOCs) signatures in Mycobacterium tuberculosis infected guinea pigs; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
2,320,307.00 | 2 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to enable the discovery and development of more effective drug regimens for drug sensitive and drug resistant tuberculosis (TB) disease; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
100,000.00 | 24 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to block residual malaria transmission by vaccinating cattle with selected, essential antigens from the mosquito Anopheles so that they produce antibodies that are lethal to the mosquitoes that feed on them.; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
44,000.00 | 31 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to test the effects of dietary rice bran and rice varietal differences in bacterial and viral pathogen disease prevention models; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
-5.26 | 33 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to facilitate a guinea pig natural transmission study, further the development of this natural transmission model, and establish cell based assays to detect M. tuberculosis infection regardless of vaccination status; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
137,749.00 | 22 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to develop a robust, inexpensive, facile point-of-care test for accurate diagnosis of tuberculosis for use in high burden, low-income countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
208,591.00 | 18 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to enable the discovery and development of more effective drug regimens for drug sensitive and drug resistant tuberculosis (TB) disease; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
50,000.00 | 29 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to reduce the incidence of malaria, lymphatic filariasis and soil transmitted helminth infections in Burkina Faso by administering the anti-parasitic drug ivermectin and insecticide treated nets during the dry-to-rainy seasonal transition; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
50,000.00 | 29 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to reduce the incidence of malaria, lymphatic filariasis and soil transmitted helminth infections in Burkina Faso by administering the anti-parasitic drug ivermectin and insecticide treated nets during the dry-to-rainy seasonal transition; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
678,939.00 | 11 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to validate a new mouse model resembling human pathology for TB drug development. Evaluation of a new murine model for testing tuberculosis chemotherapy. Investment start date: 10/24/2011 to end date: 10/31/2016. Grantee name: Colorado State University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
540,187.00 | 16 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to validate a novel approach and series of biomarkers for the diagnosis of tuberculosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
591,185.00 | 15 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to develop a robust, inexpensive, facile point-of-care test for accurate diagnosis of tuberculosis for use in high burden, low-income countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
244,913.00 | 17 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to develop methods to detect specific volatile organic compound (VOCs) signatures in Mycobacterium tuberculosis infected guinea pigs; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
862,470.00 | 9 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to determine the ability of high transmission strains of tuberculosis to grow in the relevant guinea pig small animal model; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
593,628.00 | 14 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to facilitate a guinea pig natural transmission study, further the development of this natural transmission model, and establish cell based assays to detect M. tuberculosis infection regardless of vaccination status; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
206,422.00 | 19 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to validate a new mouse model resembling human pathology for TB drug development. Evaluation of a new murine model for testing tuberculosis chemotherapy. Investment start date: 10/24/2011 to end date: 10/31/2016. Grantee name: Colorado State University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
1,000,000.00 | 8 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to test the effects of dietary rice bran and rice varietal differences in bacterial and viral pathogen disease prevention models; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
-2,678.00 | 44 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to support a discussion of what can be learned from the successes and failures of BCG and how this can be applied to the development of more effective vaccines against TB.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
-2,800.00 | 45 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to define the in vivo physiology of Mycobacterium tuberculosis and implement methods to asses metabolites found in M. tuberculosis infected tissue; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
-185.41 | 42 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to develop non-invasive phage particle based sensors for active tuberculosis. Non-Invasive Phage Particle Based Sensors for Active TB. Investment start date: 5/1/2010 to end date: 10/31/2011. Grantee name: Colorado State University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
1,005,773.00 | 7 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to evaluate the metabolic status of host granulomatous tissue and TB during drug treatment and disease relapse in the mouse model of TB and during disease progression in the mouse and non-human primate models of TB; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
1,173,007.00 | 5 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to validate a new mouse model resembling human pathology for TB drug development. Evaluation of a new murine model for testing tuberculosis chemotherapy. Investment start date: 10/24/2011 to end date: 10/31/2016. Grantee name: Colorado State University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
679,634.00 | 10 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to develop a robust, inexpensive, facile point-of-care test for accurate diagnosis of tuberculosis for use in high burden, low-income countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
600,597.00 | 12 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to validate a novel approach and series of biomarkers for the diagnosis of tuberculosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
21,120.00 | 32 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to support a discussion of what can be learned from the successes and failures of BCG and how this can be applied to the development of more effective vaccines against TB.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
-1,227.19 | 43 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to research whether providing endectocides, drugs that kill parasitic worms, to animals and humans will effectively kill mosquitoes which feed on them; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
100,000.00 | 24 | Nutrition/basic nutrition | https://iatiregistry.org/publisher/bmgf | -- | to screen a diverse, global set of rice varieties to identify bioactive components in the bran that augment mucosal immunity against enteric bacterial pathogens; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
100,000.00 | 24 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to develop non-invasive phage particle based sensors for active tuberculosis. Non-Invasive Phage Particle Based Sensors for Active TB. Investment start date: 5/1/2010 to end date: 10/31/2011. Grantee name: Colorado State University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
600,009.00 | 13 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to define the in vivo physiology of Mycobacterium tuberculosis and implement methods to asses metabolites found in M. tuberculosis infected tissue; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
200,442.00 | 20 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to provide standardized models for Tuberculosis drug discovery. TB Assay Standardization. Investment start date: 10/1/2007 to end date: 9/30/2011. Grantee name: Colorado State University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
100,000.00 | 24 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop a novel arthropod-based vaccine system against leishmaniasis. Novel arthropod-based vaccine system against leishmaniasis.. Investment start date: 5/1/2009 to end date: 10/31/2010. Grantee name: Colorado State University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
100,000.00 | 24 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to research whether providing endectocides, drugs that kill parasitic worms, to animals and humans will effectively kill mosquitoes which feed on them; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
1,248,384.00 | 4 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to study the basis of why a small number of tuberculosis bacteria still persist in vivo after drug therapy; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
1,101,761.00 | 6 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to provide standardized models for Tuberculosis drug discovery. TB Assay Standardization. Investment start date: 10/1/2007 to end date: 9/30/2011. Grantee name: Colorado State University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
2,599,996.00 | 1 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to define the in vivo physiology of Mycobacterium tuberculosis and implement methods to asses metabolites found in M. tuberculosis infected tissue; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. |